Logo image of BA

BOEING CO/THE (BA) Stock Fundamental Analysis

NYSE:BA - New York Stock Exchange, Inc. - US0970231058 - Common Stock - Currency: USD

154.18  -4.25 (-2.68%)

After market: 153.701 -0.48 (-0.31%)

Fundamental Rating

1

Overall BA gets a fundamental rating of 1 out of 10. We evaluated BA against 65 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of BA have multiple concerns. BA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

BA had negative earnings in the past year.
In the past year BA has reported a negative cash flow from operations.
BA had negative earnings in each of the past 5 years.
In multiple years BA reported negative operating cash flow during the last 5 years.
BA Yearly Net Income VS EBIT VS OCF VS FCFBA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

Looking at the Return On Assets, with a value of -7.59%, BA is doing worse than 72.31% of the companies in the same industry.
Industry RankSector Rank
ROA -7.59%
ROE N/A
ROIC N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BA Yearly ROA, ROE, ROICBA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

BA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BA Yearly Profit, Operating, Gross MarginsBA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1

2. Health

2.1 Basic Checks

BA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BA has been increased compared to 1 year ago.
The number of shares outstanding for BA has been increased compared to 5 years ago.
Compared to 1 year ago, BA has an improved debt to assets ratio.
BA Yearly Shares OutstandingBA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BA Yearly Total Debt VS Total AssetsBA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

Based on the Altman-Z score of 1.00, we must say that BA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BA (1.00) is worse than 81.54% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1
ROIC/WACCN/A
WACC8.79%
BA Yearly LT Debt VS Equity VS FCFBA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

BA has a Current Ratio of 1.32. This is a normal value and indicates that BA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.32, BA is doing worse than 73.85% of the companies in the same industry.
A Quick Ratio of 0.42 indicates that BA may have some problems paying its short term obligations.
BA has a worse Quick ratio (0.42) than 93.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.42
BA Yearly Current Assets VS Current LiabilitesBA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

3

3. Growth

3.1 Past

The earnings per share for BA have decreased strongly by -250.00% in the last year.
Looking at the last year, BA shows a very negative growth in Revenue. The Revenue has decreased by -14.50% in the last year.
Measured over the past years, BA shows a decrease in Revenue. The Revenue has been decreasing by -4.74% on average per year.
EPS 1Y (TTM)-250%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1155.32%
Revenue 1Y (TTM)-14.5%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%-30.77%

3.2 Future

The Earnings Per Share is expected to grow by 20.11% on average over the next years. This is a very strong growth
BA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.55% yearly.
EPS Next Y92.35%
EPS Next 2Y48.3%
EPS Next 3Y33.32%
EPS Next 5Y20.11%
Revenue Next Year24.84%
Revenue Next 2Y20.42%
Revenue Next 3Y17.17%
Revenue Next 5Y15.55%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BA Yearly Revenue VS EstimatesBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B
BA Yearly EPS VS EstimatesBA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 -10 -20

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BA. In the last year negative earnings were reported.
Also next year BA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BA Price Earnings VS Forward Price EarningsBA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BA Per share dataBA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

BA's earnings are expected to grow with 33.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.3%
EPS Next 3Y33.32%

0

5. Dividend

5.1 Amount

No dividends for BA!.
Industry RankSector Rank
Dividend Yield N/A

BOEING CO/THE

NYSE:BA (3/7/2025, 8:06:33 PM)

After market: 153.701 -0.48 (-0.31%)

154.18

-4.25 (-2.68%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)01-28 2025-01-28/bmo
Earnings (Next)04-22 2025-04-22/bmo
Inst Owners75.41%
Inst Owner Change38.64%
Ins Owners0.04%
Ins Owner Change6.22%
Market Cap115.65B
Analysts77.78
Price Target203.66 (32.09%)
Short Float %2.56%
Short Ratio2.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend2.02
Dividend Growth(5Y)-11.02%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-43.7%
Min EPS beat(2)-91.07%
Max EPS beat(2)3.66%
EPS beat(4)2
Avg EPS beat(4)-23.11%
Min EPS beat(4)-91.07%
Max EPS beat(4)37.77%
EPS beat(8)4
Avg EPS beat(8)-7.22%
EPS beat(12)4
Avg EPS beat(12)-872.64%
EPS beat(16)5
Avg EPS beat(16)-763.86%
Revenue beat(2)0
Avg Revenue beat(2)-5.74%
Min Revenue beat(2)-8.71%
Max Revenue beat(2)-2.77%
Revenue beat(4)0
Avg Revenue beat(4)-4.33%
Min Revenue beat(4)-8.71%
Max Revenue beat(4)-0.87%
Revenue beat(8)2
Avg Revenue beat(8)-1.93%
Revenue beat(12)2
Avg Revenue beat(12)-4.68%
Revenue beat(16)2
Avg Revenue beat(16)-5.02%
PT rev (1m)6.86%
PT rev (3m)8.9%
EPS NQ rev (1m)1.88%
EPS NQ rev (3m)-168.28%
EPS NY rev (1m)-30893.5%
EPS NY rev (3m)-428.99%
Revenue NQ rev (1m)1.88%
Revenue NQ rev (3m)-0.33%
Revenue NY rev (1m)0.44%
Revenue NY rev (3m)-1.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.74
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-20.37
EYN/A
EPS(NY)-1.56
Fwd EYN/A
FCF(TTM)-19.2
FCFYN/A
OCF(TTM)-16.11
OCFYN/A
SpS88.68
BVpS-5.21
TBVpS-18.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.59%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 126.25%
Cap/Sales 3.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.42
Altman-Z 1
F-Score2
WACC8.79%
ROIC/WACCN/A
Cap/Depr(3y)90.02%
Cap/Depr(5y)74.76%
Cap/Sales(3y)2.43%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-250%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1155.32%
EPS Next Y92.35%
EPS Next 2Y48.3%
EPS Next 3Y33.32%
EPS Next 5Y20.11%
Revenue 1Y (TTM)-14.5%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%-30.77%
Revenue Next Year24.84%
Revenue Next 2Y20.42%
Revenue Next 3Y17.17%
Revenue Next 5Y15.55%
EBIT growth 1Y-1218.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year149.06%
EBIT Next 3Y50.8%
EBIT Next 5Y32.37%
FCF growth 1Y-424.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-302.68%
OCF growth 3YN/A
OCF growth 5YN/A